Niraparib as Maintenance Therapy in Germline ATM-mutated and Somatic BRCA2-mutated Ovarian Cancer with Brain Metastases: A Case Report and Literature Review

Brain metastases from epithelial ovarian cancer are very rare with an incidence of only 1–2.5%. Many therapeutic methods such as surgery, irradiation and chemotherapy do produce survival benefits, but the overall outcome remains unsatisfactory. The BRCA (breast cancer susceptibility gene) mutation s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Mengyu, Cheng, Jiejun, Wu, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755878/
https://www.ncbi.nlm.nih.gov/pubmed/33376347
http://dx.doi.org/10.2147/OTT.S281302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755878/
https://www.ncbi.nlm.nih.gov/pubmed/33376347
http://dx.doi.org/10.2147/OTT.S281302

Ejemplares similares